Orbimed Advisors LLC Compass Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $2.8 Billion
- Q2 2025
A detailed history of Orbimed Advisors LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 15,219,994 shares of CMPX stock, worth $56.5 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
15,219,994
Previous 22,362,850
31.94%
Holding current value
$56.5 Million
Previous $42.5 Million
6.87%
% of portfolio
1.41%
Previous 1.32%
Shares
4 transactions
Others Institutions Holding CMPX
# of Institutions
106Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Tang Capital Management LLC San Diego, CA13.5MShares$50.1 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$37.2 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$26.5 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$24.5 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.04MShares$22.4 Million3.33% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $376M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...